Navigation Links
AEterna Zentaris Receives US$5.5 Million from Institutional Investors
Date:10/24/2009

licly announce the result of any revisions to any of the forward-looking statements contained herein to reflect future results, events or developments except if we are required by a governmental authority or applicable law.

SOURCE AETERNA ZENTARIS INC.


'/>"/>
SOURCE AETERNA ZENTARIS INC.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. AEterna Zentaris completes management team with the appointment of Chief Medical Officer
2. AEterna Zentaris to Present at Upcoming UBS Global Life Sciences Conference in New York
3. AEterna Zentaris Announces Outcome of Managements Strategic Review
4. AEterna Zentaris to Further Develop Three Follow-up Multi-targeted Cytotoxic Candidates to AEZS-112 as Potential Novel Cancer Treatment
5. AEterna Zentaris Reports First Patients Treated with Anti-Cancer Compound AEZS-108 in Phase 2 Trial in Ovarian and Endometrial Cancers
6. AEterna Zentaris to Present at the Upcoming Roth Capital Partners 20th Annual OC Growth Stock Conference in Dana Point, California
7. Aeterna Zentaris to Announce Fourth Quarter and Full-Year 2007 Financial and Operating Results on March 5, 2008
8. AEterna Zentaris Announces the Departure of SVP, Administrative and Legal Affairs
9. AEterna Zentaris and Paladin Labs Announce Sale and Purchase of Miltefosine Rights
10. Aeterna Zentaris Reports Fourth Quarter and Full-Year 2007 Financial and Operating Results
11. Aeterna Zentaris Begins Second Phase 3 Trial of Cetrorelix for Benign Prostatic Hyperplasia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... FREMONT, Calif., Dec. 14 Vermillion, ... company, today announced William C. Wallen, Ph.D. ... and Development for IDEXX Laboratories, will be ... of Vermillion,s bankruptcy plan. ,, "Bill ... development experience in diagnostics and biotechnology," said ...
(Date:12/14/2009)... Joins with State Biotech Leaders to Develop ... and Development while Boosting Rhode Island,s Growing ... PROVIDENCE, R.I., Dec. 14 Several ... research, medicine and biotechnology gathered today at ... the importance of medical innovation in Rhode ...
(Date:12/14/2009)... 14 Boston Scientific Corporation (NYSE: ... offering of $2 billion aggregate principal amount of its ... The public offering consists of $850 million of 4.50 ... percent notes due January 2020 and $300 million of ... plans to use the net proceeds for general corporate ...
(Date:12/14/2009)... SAN CARLOS, Calif., Dec. 14 Nektar ... Dennis Winger has been appointed to serve on ... highly-respected biopharmaceutical industry leader with over 35 years ... strategy. ,, "Dennis brings to Nektar extensive industry ... evolution," said Howard W. Robin, President and CEO ...
Breaking Biology Technology:Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 2Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 3Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 4Former Congressman Dick Gephardt Brings National Spotlight to Rhode Island with 'Best and Brightest Forum on Medical Innovation' 2Former Congressman Dick Gephardt Brings National Spotlight to Rhode Island with 'Best and Brightest Forum on Medical Innovation' 3Former Congressman Dick Gephardt Brings National Spotlight to Rhode Island with 'Best and Brightest Forum on Medical Innovation' 4Boston Scientific Announces Completion of $2 Billion Senior Notes Offering 2Boston Scientific Announces Completion of $2 Billion Senior Notes Offering 3Dennis Winger Joins Nektar Therapeutics' Board of Directors 2Dennis Winger Joins Nektar Therapeutics' Board of Directors 3
... Corporation, a leading manufacturer of next-generation portable lasers ... increased dramatically in 2008 over 2007. The company,s ... helped to more than offset current economic conditions, ... sales month for Aerolase, and 2008 overall represented ...
... Jan. 23 Peter T. Wilderotter, president and CEO ... following statement today in response to FDA clearance of ... is an exciting first step for Geron and for ... to advances in medical research. There has been so ...
... Spinal Cord Injury , Geron Corporation ... and Drug,Administration (FDA) has granted clearance of the company,s Investigational,New ... patients with,acute spinal cord injury. The clearance enables Geron to ... stem (hESC) cell-based therapy,in man. , ...
Other Biology Technology:Aerolase Reports Strong Sales in 2008 for Portable Aesthetic Lasers 2Aerolase Reports Strong Sales in 2008 for Portable Aesthetic Lasers 3Christopher and Dana Reeve Foundation Response to FDA Clearance of Geron's Clinical Trial 2MultiVu Video Feed: Geron Receives FDA Clearance to Begin World's First Human Clinical Trial of Embryonic Stem Cell-Based Therapy 2
(Date:12/13/2009)... that may help to engineer plants that take advantage ... The finding could help to engineer crops that take ... the carbon dioxide they need for photosynthesis through microscopic ... each molecule of the gas gained, they lose hundreds ... can tighten to save water when CO 2 ...
(Date:12/11/2009)... LAKeeping with the global "green" trend, educators ... lessons to enhance students, science knowledge. Studies ... the curriculum raises not just science scoresenvironmental-based ... in other subject areas. Naturally, educators are ... these relevant lessons into the classroom in ...
(Date:12/11/2009)... How does a cell manage to identify and degrade ... the body against serious diseases? The researchers Sabine C. ... Ernst Jarosch of the Max Delbrck Center for Molecular ... piece in this puzzle. In an enzyme complex that ... proteins, they discovered a scaffold regulating the identification and ...
Breaking Biology News(10 mins):Newly identified enzymes help plants sense elevated CO2 and could lead to water-wise crops 2Newly identified enzymes help plants sense elevated CO2 and could lead to water-wise crops 3Students learn environmental stewardship, improve science scores 2MDC researchers identify a scaffold regulating protein disposal 22009 Charles River Laboratories Excellence in Refinement Award 9785 1Giant Eagle Pharmacy to Offer Customers in Ohio a Dose of Economic Relief Through Free Antibiotics Program 56196 1Giant Eagle Pharmacy to Offer Customers in Ohio a Dose of Economic Relief Through Free Antibiotics Program 56196 2Giant Eagle Pharmacy to Offer Customers in Ohio a Dose of Economic Relief Through Free Antibiotics Program 56196 3Is it Exam Time for Students Already 3F 56191 1Is it Exam Time for Students Already 3F 56191 2Is it Exam Time for Students Already 3F 56191 3Is it Exam Time for Students Already 3F 56191 4Is it Exam Time for Students Already 3F 56191 5
... the University of Illinois have developed a simple and ... This new approach will enable them to construct the ... the secrets hidden in their stripes. , Their ... in the journal Nature Methods. , Fruit flies ...
... likelihood of developing bipolar disorder depends in part on the ... in the brain, none of which is powerful enough to ... However, targeting the enzyme produced by one of these genes ... The research was conducted by scientists at the National Institutes ...
... their effects on fat development, researchers have discovered that ... mice without some of the side effects attributed to ... harmine, was first isolated more than 150 years ago ... around the world, the team reports in the May ...
Other Biology News:New technique will produce a better chromosome map 2New technique will produce a better chromosome map 3Genetic roots of bipolar disorder revealed by first genome-wide study of illness 2Genetic roots of bipolar disorder revealed by first genome-wide study of illness 3Fat screen delivers plant-derived chemical with antidiabetic effects 2